BRAF and melanoma: The initial disparity between PTs and DCCs regarding BRAF mutations, in addition to the strong selective advantage this mutations endows DCCs with during colony formation, explains both the observed disparity for BRAF mutations between PTs and metastases31,33–35 and the increased frequency of BRAF mutations in metastases compared to early RGP melanomas.